Broadfin Capital, LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 71 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$18,422,000
+31.4%
1,236,368
-9.6%
2.47%
-4.8%
Q3 2019$14,016,000
-20.2%
1,367,377
-17.4%
2.59%
-32.2%
Q2 2019$17,555,000
+549.7%
1,656,137
+756.8%
3.82%
+584.4%
Q1 2019$2,702,000
+85.6%
193,300
+34.9%
0.56%
+192.1%
Q4 2018$1,456,000143,3000.19%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 217,029$2,225,0006.42%
Knoll Capital Management, LLC 350,238$3,590,0003.29%
INTERWEST VENTURE MANAGEMENT CO 764,918$7,840,0003.01%
Broadfin Capital, LLC 1,367,377$14,016,0002.59%
P.A.W. CAPITAL CORP 200,000$2,050,0002.56%
683 Capital Management, LLC 1,860,529$19,071,0002.12%
EcoR1 Capital, LLC 1,060,043$10,865,0001.37%
MANGROVE PARTNERS IM, LLC 847,284$8,685,0001.05%
KNOTT DAVID M 234,448$2,403,0001.01%
Trellus Management Company, LLC 85,000$871,0000.87%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders